BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14614047)

  • 1. Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas.
    Kim SG; Wu TT; Lee JH; Yun YK; Issa JP; Hamilton SR; Rashid A
    Mod Pathol; 2003 Nov; 16(11):1086-94. PubMed ID: 14614047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients.
    Mohr VH; Vortmeyer AO; Zhuang Z; Libutti SK; Walther MM; Choyke PL; Zbar B; Linehan WM; Lubensky IA
    Am J Pathol; 2000 Nov; 157(5):1615-21. PubMed ID: 11073821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q.
    Moore PS; Zamboni G; Brighenti A; Lissandrini D; Antonello D; Capelli P; Rigaud G; Falconi M; Scarpa A
    Am J Pathol; 2001 Jan; 158(1):317-21. PubMed ID: 11141506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
    Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
    Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
    Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
    J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor.
    Kim SY; Lee JM; Kim SH; Shin KS; Kim YJ; An SK; Han CJ; Han JK; Choi BI
    AJR Am J Roentgenol; 2006 Nov; 187(5):1192-8. PubMed ID: 17056905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.
    Shih IM; Yan H; Speyrer D; Shmookler BM; Sugarbaker PH; Ronnett BM
    Am J Surg Pathol; 2001 Aug; 25(8):1095-9. PubMed ID: 11474297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
    Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development.
    van den Berg A; Dijkhuizen T; Draaijers TG; Hulsbeek MM; Maher ER; van den Berg E; Störkel S; Buys CH
    Genes Chromosomes Cancer; 1997 Aug; 19(4):228-32. PubMed ID: 9258657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas?
    Wada K; Takada T; Yasuda H; Amano H; Yoshida M; Sugimoto M; Irie H
    J Gastrointest Surg; 2004; 8(3):289-96. PubMed ID: 15019925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas.
    Fogt F; Vortmeyer AO; Stolte M; Mueller E; Mueller J; Noffsinger A; Poremba C; Zhuang Z
    Hum Pathol; 1998 Sep; 29(9):961-4. PubMed ID: 9744312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
    Wada K
    J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of von Hippel-Lindau gene product (pVHL) and S100P in cystic neoplasms of the pancreas--with an implication for their roles in tumorigenesis.
    Liu H; Shi J; Wang HL; Zhang J; Brown RE; Wilkerson M; Lin F
    Ann Clin Lab Sci; 2012; 42(2):109-17. PubMed ID: 22585604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma ex microcystic adenoma of the pancreas: a report of a novel form of malignancy in serous neoplasms.
    Zhu H; Qin L; Zhong M; Gordon R; Raoufi M; Hechtman JF; Schwartz M; Roayaie S; Klimstra DS
    Am J Surg Pathol; 2012 Feb; 36(2):305-10. PubMed ID: 22189969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
    Schoedel KE; Finkelstein SD; Ohori NP
    Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serous neoplasms of the pancreas constitute a continuous spectrum of morphological patterns rather than distinct clinico-pathological variants. A study of 40 cases.
    Pająk J; Liszka Ł; Mrowiec S; Zielińska-Pająk E; Gołka D; Lampe P
    Pol J Pathol; 2011 Dec; 62(4):206-17. PubMed ID: 22246906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.